Raymond James Financial
EXAS

Raymond James Financial’s Exact Sciences EXAS Stock Holding History

Raymond James Financial’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-92,671
Closed -$9.41M – 5346
2025
Q4 		$9.41M Sell
92,671
-37,785
-29% -$3.03M ﹤0.01% 2014
2025
Q3 		$7.14M Buy
130,456
+2,026
+2% +$101K ﹤0.01% 2194
2025
Q2 		$6.82M Sell
128,430
-15,316
-11% -$778K ﹤0.01% 2159
2025
Q1 		$6.22M Sell
143,746
-27,307
-16% -$1.38M ﹤0.01% 2183
2024
Q4 		$9.61M Buy
+171,053
New +$10.6M ﹤0.01% 1880

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Raymond James Financial's EXAS Position: Q1 2026 in Review

Raymond James Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 92,671 shares — an estimated $9.41M sold.

Raymond James Financial first reported a position in EXAS in Q4 2024 and held it in 5 quarters. The position peaked at $9.61M in Q4 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Raymond James Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Raymond James Financial sold 92,671 Exact Sciences shares in Q1 2026, an estimated $9.41M.
  • Raymond James Financial first reported a position in Exact Sciences in Q4 2024 and held it in 5 quarters.
  • Raymond James Financial's Exact Sciences position peaked at $9.61M in Q4 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.